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Background: Mitochondrial glutaredoxin 2 is a member of the oxidoreductase family with disulfide reductase activity that
repairs thiol oxidation-damaged proteins.
Results: Glutaredoxin 2 null mice develop early cataracts during aging.
Conclusion: Glutaredoxin 2 deletion causes mitochondrial malfunction and cataract formation and is a good model for
studying the mechanism of human age-related cataracts.
Significance: Thiol oxidation repair system is essential for lens transparency.
Abbreviations: PSSG — S-glutathionylated protein; PSSC — protein-S-S-cysteine; DCIP — 2,6-dichloroindophenol;
VDAC — voltage-dependent anion channel; PSSP — protein-protein disulfide; Trx — thioredoxin; Grx — glutaredoxin;
ARC — age-related cataract; ETS — electron transport system; PSH — protein sulfhydryl

Abstract
Glutaredoxin 2 (Grx2) is an isozyme of glutaredoxin1 (thioltransferase) present in the mitochondria and nucleus with disulfide reductase and peroxidase activities, and it controls thiol/
disulfide balance in cells. In this study, we investigated whether
Grx2 gene deletion could induce faster age-related cataract
formation and elucidated the biochemical changes effected by
Grx2 gene deletion that may contribute to lens opacity. Slit lamp
was used to examine the lenses in Grx2 knock-out (KO) mice
and age-matched wild-type (WT) mice ages 1 to 16 months. In
the Grx2 null mice, the lens nuclear opacity began at 5 months,
3 months sooner than that of the control mice, and the progression of cataracts was also much faster than the age-matched
controls. Lenses of KO mice contained lower levels of protein
thiols and GSH with a significant accumulation of S-glutathionylated proteins. Actin, αA-crystallin, and βB2-crystallin were
identified by Western blot and mass spectroscopy as the major
S-glutathionylated proteins in the lenses of 16-month-old Grx2
KO mice. Compared with the WT control, the lens of Grx2 KO
mice had only 50% of the activity in complex I and complex
IV and less than 10% of the ATP pool. It was concluded that
Grx2 gene deletion altered the function of lens structural proteins through S-glutathionylation and also caused severe disturbance in mitochondrial function. These combined alterations affected lens transparency.
Keywords: Age-related Cataract, Electron Transport System,
Glutaredoxin 2, Oxidative Stress, α-Crystallin Protein
Introduction
Oxidative stress is considered to associate closely with aging (1) and many diseases, including Alzheimer (2), Parkinson

(3), cancer (4), retina degeneration (5), and cataract of the eye
(6, 7). Under oxidative stress, the thiol groups within proteins
(PSH) are among the most oxidant-sensitive targets and can undergo a variety of reversible and irreversible redox modifications. Protein S-glutathionylation, the reversible formation of a
mixed disulfide (PSSG)2 between protein thiols (PSH) and oxidized glutathione (GSSG), appears to be the most important
mode of thiol oxidation. PSSG formation can potentially affect
protein/enzyme structure, function, and activity or even disrupt cell signaling, depending on the importance of the cysteine residue in carrying out protein/enzyme function (7–10).
Because of the physical locale, the eye lens is vulnerable to
oxidation, and cataract formation in the aging population is one
of the leading causes of blindness in the world (11). The lens is
a protein-rich avascular organ whose main function is to maintain transparency so that the incident light can be transmitted
and focused on the retina for vision. Lens structural proteins
are SH-rich and present in a reduced state with tight packing to
provide the lens with the necessary refractive power and transparency (12). The lens has a single anterior layer of epithelial
cells, which continuously differentiate into fiber cells that lie
concentrically below the epithelium forming the major bulk of
the lens organ. The structural proteins in these inactive organelle-free fiber cells once modified can accumulate with time and
alter lens functions. Extensive research has shown that oxidative stress-induced protein modification is a major risk factor
for lens transparency loss. In such cases, the lens proteins are
cross-linked and aggregated, forming high molecular weight
molecules that can scatter light leading to lens opacity and cataract development. Such morphological and functional changes
of lens often occur during aging, as is the case of age-related
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cataracts in humans (7). Oxidatively modified proteins are
found in animal and human lenses as a function of age (13),
more so in an opaque lens where the level of accumulation is
proportional to the severity of the opacity (14). The protein thiols are conjugated with GSSG to form PSSG or with oxidized
free cysteine to form protein-S-S-cysteine (PSSC) (15). It is speculated (7, 16) that S-glutathionylated proteins may undergo a
thiol transfer into protein-protein disulfides (PSSPs), which
are elevated in the water-insoluble high molecular weight protein fractions of old or cataractous lenses. The above phenomenon is often accompanied by the loss of free glutathione both
in old and in opaque lenses. Therefore, sulfhydryl homeostasis in the lens is critical for preserving its physiological function and maintaining its transparency. The lens is rich in GSH
pools and other small antioxidant molecules such as ascorbate
as well as antioxidant enzymes, including GSH peroxidase, catalase, and superoxide dismutase (12, 17), which can remove oxidants and protect the lens from extensive oxidative damage.
However, during aging some of these antioxidants or antioxidant enzymes are either depleted or weakened. Therefore, the
accumulated thiol-oxidized proteins require an efficient system
to reverse or repair the damage.
In recent years, two thiol repair systems have been identified
in the lens similar to other tissues. The first is the GSH-dependent glutaredoxin (Grx) system, which reduces the protein thiols that have been oxidized into protein-thiol mixed disulfides
and favors PSSG over PSSC (18–20). The second repair system
is the NADPH-dependent thioredoxin (Trx) system, which reduces the protein thiols that have been oxidized and formed
PSSPs and restores their proper structure and original physiological function (21, 22). Both Grx and Trx belong to the oxidoreductase superfamily and are found in all living organisms.
Grx has two isoforms in the human lens, glutaredoxin 1 (Grx1,
also called thioltransferase) and glutaredoxin 2 (Grx2). Grx1 is
a small 12-kDa cytosolic protein, which is well studied in the
mammalian Grxs family, and its important roles in regulating
cytosolic thiol/disulfide balance and various cellular functions
have been established (23–26). The mitochondrial Grx2, however, was only discovered more recently (27, 28), with a molecular mass of 16 kDa and only 34% sequence identity with Grx1.
Human Grx2 is characterized as an iron-sulfur protein and a redox sensor. It is present as an inactive dimer bridged by a [2Fe2S]2+ cluster but is monomerized and activated under oxidative
stress conditions (29). Grx2 is present in many tissues, including the brain, liver, heart, and the pancreas. In the eye, Grx2 has
been found in almost all ocular tissues, including the cornea,
iris, lens, retina, and optic nerve (30). Extensive studies have
been carried out in the lens, demonstrating that the lens Grx2
shows disulfide reductase (27), peroxidase (31), ascorbate recycling activities, and anti-apoptotic properties (32). Both Grx1
and Grx2 can be up-regulated under oxidative stress conditions
(32, 33) where, as a thiol repair enzymes, they are thought to
provide a first line of defense against protein oxidation or misfolded protein aggregation.
Recently, the Grx system has received increasing attention
because of its potential association with cardiovascular and
neurological disorders, as well as age-related macular degeneration and cancer. Evidence from recent studies suggests that
Grx2 may control mitochondrial redox balance and mitochondrial function, and it may also regulate cell apoptosis (34, 35).
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Grx2 has been shown to deglutathionylate the S-glutathionylated proteins and thereby regulate several mitochondrial targets, including complex I (36), and uncoupling protein-3 (37)
of the respiratory chain. Grx2 is thus closely involved in energy homeostasis and ATP production in cells. Recently, we
have found that Grx2 overexpression could protect human
lens epithelial cells from H2O2-induced cell apoptosis via its
ability to prevent S-glutathionylation in mitochondrial complex I (36). Similarly, primary lens epithelial cells isolated
from the Grx2 knock-out (KO) mice also exhibited unusual
sensitivity to oxidation. Imported recombinant Grx2 protein
could rescue the cells from oxidative stress-induced cell apoptosis (38). Although these findings may imply the importance
of Grx2 in mitochondrial function, little work has been done
in vivo, and the roles of Grx2 in aging and in lens transparency
are not well understood. We hypothesized previously (7) that
unchecked PSSG formation under oxidative stress is the first
major protein thiol modification that may trigger the cascading events in lens protein/enzyme function and activity loss,
protein aggregation, and cataract formation. We further hypothesized that Grx is the key enzyme to prevent PSSG accumulation and preserve lens transparency. The purpose of this
study is to test the hypothesis in vivo using the Grx2 knockout mouse as a model. We found that Grx2 deletion accelerated cataract development during aging and that these lenses
showed extensive PSSG accumulation in structural proteins
and a severely compromised electron transport system and
ATP production.
Experimental Procedures
Materials — NADPH, GSH, dithiothreitol (DTT),
5′,5′-dithiobis(2-nitrobanzoic acid), β-hydroxyethyl disulfide,
BSA, 2,6-dichloroindophenol (DCIP), decylubiquinone, antimycin-A, and all other chemicals were obtained from Sigma
unless otherwise stated. Bicinchoninic acid (BCA) protein assay reagent and SuperSignal West Chemiluminescent substrate
were from Pierce. Antibodies against actin, αA-crystallin, βB2
crystallin, β-actin, complex I 75-kDa subunit, and complex IV
subunit IV were purchased from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA). Anti-glutathione monoclonal antibody (antiPSSG antibody) was purchased from ViroGen (Watertown,
MA). Anti-Grx2 antibody was purchased from Abcam (Cambridge, MA). Protein A/G magnetic beads were purchased
from Thermo (Waltham, MA).
Generation of Grx2 Knock-out Mice — Custom screening of
a bacterial artificial chromosome (BAC) library, which carries
strain 129SV mouse genomic DNA, by hybridization with the
mouse Grx2 cDNA was conducted by Invitrogen. The screening
identified three positive clones. The DNA fragments containing
the entire mouse Grx2 gene in the BAC clones were then subcloned into vector pKS (Stratagene, La Jolla, CA) for restriction
mapping and DNA sequencing. A targeting vector, in which
exon 2 and some of the flanking intron sequences were deleted,
was constructed using the plasmid pPNT as backbone (Figure
1A) (39). The targeting vector was linearized by digestion with
restriction enzyme NotI and then transfected into R1 embryonic stem (ES) cells (40). Screening of 360 ES clones by Southern blot analysis of PstI-digested genomic DNA allowed identification of a total of 51 clones (14.2%) that contain the targeted
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Figure 1. Targeted disruption of the mouse Grx2 gene. A, genomic
structure and partial restriction map of the mouse Grx2 locus (top), the
targeting vector (middle), and the targeted locus (bottom) are shown.
The opened and black boxes represent the protein coding regions and
noncoding regions in the exons, respectively. The number of exons is
indicated below each exon. The striped box on top of the restriction
map of the Grx2 locus represents the 3′ external sequence used for
probing the DNA blot filters. B, BamHI; E, EcoRI; H, HindIII; N, NotI; X,
XbaI; neo, neomycin resistance cassette; TK, herpes thymidine kinase
gene under the control of a mouse promoter of the phosphoglycerate
kinase-1 (Pgk-1) gene. Neo, neomycin resistance cassette. The sizes
of the PstI restriction fragments from wild-type and targeted loci hybridized with the probe are shown at the top and bottom of the figure, respectively. B, Southern blot analysis of wild-type, heterozygous Grx2
knock-out, and homozygous Grx2 knock-out mice. The 6.9-kb hybridization band is derived from the wild-type Grx2 allele, and 4.0-kb hybridization band the mutated allele. The 1.3-kb hybridization fragment
is derived from the PstI genomic fragment containing exon 4 from both
the wild-type and the mutated alleles. +/+, +/−, and −/− represent wildtype, heterozygous Grx2 knock-out, and homozygous Grx2 knock-out
mice, respectively.

mutation in the Grx2 gene (Figure 1A). Clones 29, 91, 122 and
190 were then microinjected into mouse blastocysts harvested
from C57BL/6 mice for generation of chimeric mice (41). All
male chimeric mice derived from these ES clones showed germ
line transmission of the 129SV chromosomes into their progeny, resulting in the generation of heterozygous Grx2 knockout mice (Figure 1B). Homozygous knock-out mice were then
generated by breeding of heterozygous knock-out mice (Figure 1B). The homozygous knock-out mice are healthy and fertile upon observation until 8 months of age. The heterozygous
Grx2 knock-out mice in the 129SV and C57Bl/6 hybrid background were then backcrossed into C57BL/B mice to generate homozygous Grx2 knock-out mice and wild-type mice that
were used in this study.
Expression Studies of Various Tissues from Wild-type and
Heterozygous and Homozygous Grx2 Knock-out Mice — The
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methods for isolation of RNA and proteins from mouse tissues and blot analysis have previously been described (42).
A specific anti-Grx2 antibody used was from Abcam (catalog
no. ab85267).
Reverse Transcription-Polymerase Chain Reaction (RTPCR) of Grx2 mRNA from Hearts of Wild-type and Heterozygous and Homozygous Grx2 Knock-out Mice — One microgram of total heart RNA from mice of each genotype was
used in reverse transcription using the iScript cDNA synthesis
kit (Bio-Rad). The synthesized Grx2 cDNA was then PCR-amplified with forward primer GGGACCTTTGGCTATGTCCT
(from exon 1) and reverse primer TCTTTGTGAAGCCTGTGAGTGT (from exon 4) using the GoTaq GreenMaster Mix
(Promega, Madison, WI). The PCR-amplified DNA fragments
were initially analyzed on an agarose gel and then purified for
sequence determination.
Cataract Prevalence Rate and Opacity Scoring — For the
present eye lens studies, we only use the homozygous Grx2 KO
mouse (Grx2−/−) model. The lenses in Grx2 null mice and agematched wild-type (WT) mice of the same background, both
sexes at 3–16 months old were examined and imaged using a
slit lamp ophthalmoscope (66 Instrument Co, Suzhou, China),
equipped with a Sony digital camera, after the pupils were dilated with tropicamide phenylephrine eye drops (Santen Pharmaceutical Co., Ltd.) under nonanesthetized conditions. The
eight age groups of mice were 3, 5, 7, 8, 9, 11, 13, and 16 months
old. The number of Grx2 KO mouse eyes was 12 (3 months),
10 (5 months), 8 (7 months), 6 (8 months), 12 (9 months), 12 (11
months), 10 (13 months), and 10 (16 months), whereas the number of wild-type mouse eyes was 12 (3 months), 12 (5 months),
8 (7 months), 10 (8 months), 10 (9 months), 10 (11 months), 8 (13
months), and 8 (16 months). The LOCS II system (43) was used
for cataract classification and grading (score). For the nucleus,
score 0 illustrates a clear nucleus; score 1 is an early degree of
nuclear opalescence; score 2 is a moderately advanced nuclear
opacification, and score 3 represents an advanced nuclear opalescence. For the cortex, score 0 is clear; score 1 shows a small
mini-spoke inside the pupillary margin; score 2 contains cortical spokes that obscure slightly more than two full quadrants;
score 3 illustrates ~50% opacification of the intra-pupillary
zone, and score 4 means ~90% opacification of the intra-pupillary zone. For the posterior subcapsular region, score 1 illustrates a cataract filling ~3% of the area; score 2 stands for ~30%
opacification; score 3 illustrates about 50%, and score 4 shows
>50% opacification of the area. The cataract score reported in
this study is calculated based on the sum of the scores from nucleus, cortex, and posterior subcapsular opacity divided by the
total eyes examined.
Isolation of Mitochondria from Mouse Lenses — The mitochondrial fraction was isolated according to the modified procedure of Rehncrona et al. (44). Briefly, each lens was homogenized in 1 ml of ice-cold buffer A (containing 225 mm mannitol,
65 mm sucrose, 1 mm EGTA, and 10 mm HEPES (pH 7.2)) using a glass-to-glass homogenizer, followed by centrifugation at
1,000 × g for 10 min at 4 °C. The supernatant was centrifuged
again at 10,000 × g for 10 min at 4 °C. The pellet was resuspended with 1 ml of buffer B (containing 225 mm mannitol,
65 mm sucrose, and 10 mm HEPES (pH 7.2)) followed by centrifugation at 10,000 × g for 10 min at 4 °C. The final mitochondrial fraction was resuspended in 100 μl of buffer B and stored
at −80 °C until used.
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Western Blot Analysis — Equal amounts of proteins were
subjected to SDS-PAGE on 12% polyacrylamide gel and transferred to a polyvinylidene difluoride (PVDF) membrane (GE
Healthcare). Detection was done using the ECL Western blotting detection system (Thermo Scientific, Rockford, IL). The
immunoblot was analyzed with an imaging system (VersaDoc
5000 MP Imaging System, Bio-Rad).
Grx2 Activity Assay — Grx2 activity was assayed according to a previously described method (27). The reaction mixture contained 0.2 mm NADPH, 0.5 mm GSH, 0.1 m potassium
phosphate buffer (pH 7.4), 0.4 units of GSSG reductase, and an
aliquot of mitochondrial fraction in a total volume of 0.5 ml.
The reaction was carried out at 30 °C following a 5-min preincubation with a substrate of 2 mm hydroxyethyl disulfide. The
decrease in absorbance of NADPH at 340 nm was monitored
for 3 min using a Beckman DU 640 spectrophotometer (Beckman, Fullerton, CA). To determine the Grx2 activity, the slope
of the linear portion of the time course for 340 nm of absorption loss in a control (Grx2-free) sample was subtracted from
the slope of the samples containing Grx2.
GSH and Protein Sulfhydryl (PSH) Group Measurement —
Each whole lens was homogenized in 1.0 ml of ice-cold buffer containing 50 mm Tris-HCl (pH 7.5), 100 mm NaCl, and 10
mm EDTA. The homogenate was centrifuged at 16,000 × g for
10 min at 4 °C. For total sulfhydryl group measurement, an
aliquot of 50 μl of the fresh lens homogenate was mixed with
150 μl of 5′,5′-dithiobis(2-nitrobanzoic acid) reagent, and the
absorbance was read at 412 nm. For GSH assay, lens homogenate was deproteinized by mixing with an equal volume of
20% trichloroacetic acid (TCA), followed by centrifugation for
10 min at 16,000 × g to remove proteins. The supernatant was
used immediately for GSH analysis by 5′,5′-dithiobis(2-nitrobenzoic acid), following the published method (45). PSH level
was calculated by subtracting the values of GSH from total
sulfhydryl groups.
Quantitation of Protein-Thiol Mixed Disulfides in the Eye
Lens — Protein-thiol mixed disulfides, protein-GSH (PSSG)
and protein-cysteine (PSSC), were quantified following the
method of Lou et al. (46) with modifications. Six mouse lenses
were pooled and homogenized in 2 ml of 10% TCA followed
by centrifugation at 1600 × g for 15 min. The pellet was thoroughly washed three times with 10% TCA to remove free GSH
and GSSG. The final pellet was then washed with 0.5 ml of
methanol/ether mixture (1:1, v/v) to remove any lipid components followed by drying on a heating block at 65 °C overnight. The dried protein pellet was weighed and ground into
fine powder, which was suspended in 125 μl of 88% formic
acid, with an addition of 0.5 ml of freshly made performic
acid. The reaction tube was kept on ice for 2.5 h with occasional swirling to thoroughly oxidize and cleave the disulfide bonds of protein-thiol mixed disulfides of PSSG and
PSSC to release glutathione sulfonic acid (GSO 3H) and cysteic acid (CSO3H), respectively. The excess performic acid was
neutralized using 90 ml of pre-chilled water followed by lyophilization. The lyophilized residue was washed into a 15ml centrifuge tube with three 3-ml aliquots of ice-cold water. The suspension was centrifuged for 15 ml at 17,000 rpm
to remove the oxidized insoluble proteins. The supernatant
was transferred to a 10-ml pear-shaped flask and lyophilized
twice. The resulting residue was subsequently suspended in
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200 μl of H2O followed by centrifugation at 16,000 × g before
using an aliquot for GSO3H and CSO3H quantification using
a Dionex anion amino acid analyzer (DX500 model, Dionex,
Sunnyvale, CA).
ATP Quantification — ATP level was measured with an
ATP bioluminescence assay kit CLS II (Roche Applied Science)
according to the manufacturer’s recommendation. Briefly, lens
homogenates were mixed with 9 volumes of boiling solution
(PBS containing 100 mm Tris and 4 mm EDTA) and incubated
for 2 min at 100 °C. The sample mix was then centrifuged at
1000 × g for 1 min, and 50 μl of the supernatant was mixed
with 50 μl of luciferase reagent by automated injection. The luminescence intensity was detected by a Fluostar Optima microplate reader (BMG Labtech, Offenburg, Germany), and integrated for 1–10 s.
Detection of PSSG with Western Blot and Immunoprecipitation — WT or Grx2 KO mouse lenses were homogenized in
50 mm Tris (pH 7.4), containing 150 mm NaCl, 10 mm iodoacetic acid, and 1% protease inhibitor mixture. The homogenates
were centrifuged at 13,000 × g for 10 min at 4 °C, followed by
protein determination. The lens proteins (120 μg) were loaded
onto SDS-polyacrylamide gels under nonreducing conditions
and probed with a specific anti-GSH antibody. For immunoprecipitation, the glutathionylated proteins were pulled down
with anti-GSH antibody, using the nonspecific mouse IgG as a
negative control. The bound proteins were eluted by 0.2 m glycine (pH 2) containing 50 mm N-ethylmaleimide, separated by
nonreducing SDS-PAGE, and visualized by silver staining or
Coomassie Blue staining.
Mass Spectrometric Identification of S-Glutathionylated
Proteins — The major bands immunoprecipitated with antiGSH antibody were excised from a Coomassie Blue-stained
SDS-polyacrylamide gel; proteins were digested overnight
with trypsin, and peptides were analyzed by liquid chromatography/tandem mass spectrometry (LC-MS/MS) as described previously (47), except gel slices were not reduced.
LTQ Velos ion trap mass spectrometer (Thermo Scientific,
San Jose, CA) was used, and five data-dependent MS2 scans
were collected following each MS survey scan. Peptide identification was performed by comparing observed MS2 spectra to theoretical fragmentation spectra of peptides generated from a protein database using Sequest (Version 27,
revision 12, Thermo Scientific). Searches included a static
modification of +57 on cysteines due to alkylation with iodoacetic acid, and a dynamic modification of +248 on cysteines to detect possible sites of glutathionylation. A mouse
version of the Swiss-Prot database was used (Swiss Institute
of Bioinformatics, Geneva, Switzerland) with added common
contaminants added, and the resulting file amended by reversing the sequence of all 16,563 entries to estimate the protein false discovery rate. Peptide and protein identifications
were then compiled using in-house software (48), using a
two unique peptide minimum per entry and a protein false
discovery rate of 5%.
Complex I Activity Assay — The enzymatic activity of
complex I was assayed according to the method of Janssen
et al. (49). In brief, 50 μg of mitochondria was mixed with 960
μl of reaction mixture containing 20 mm KH 2PO 4, 3.5 mg/
ml BSA, 60 μm DCIP, 70 μm decylubiquinone (prepared in
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dimethyl sulfoxide, DMSO), and 1 μm antimycin-A at 30 °C.
After 3 min, 20 μl of 10 mm NADH was added, and the absorbance was measured at 30-s interval for 4 min at 37 °C. After
that, 1.0 μl of rotenone (1 mm, in DMSO) was added, and the
absorbance was measured at 30-s intervals for an additional
4 min to confirm the measurement of rotenone-sensitive complex I activity. The enzyme activity was expressed as nanomoles of DCIP reduced per min/mg of protein. The substrate
DCIP, which is a water-soluble final electron acceptor, is specific for complex I because DCIP receives electrons only from
complex I and not from other nonmitochondrial NADH dehydrogenases. BSA is a necessary component in the assay mixture because it acts as a solubilization agent for rotenone and
decylubiquinone.
Complex IV Enzyme Activity Assay — The complex IV rodent enzyme activity microplate assay kit (Abcam, Cambridge,
MA) was used to determine the activity of the cytochrome c oxidase enzyme in the mouse lens, according to the manufacturer’s recommendation. Briefly, 100 μg of mitochondrial proteins
isolated from WT or Grx2 KO mouse lenses were loaded into a
96-well plate. Complex IV was immunocaptured in the 96-well
plate, and the enzyme activity was determined colorimetrically
by following the decrease in 550 nm absorbance during oxidation of reduced cytochrome c.
Statistics — Each experiment was performed at least three
times, and statistical analyses were performed using one-way
analysis of variance followed by a post hoc Tukey’s test, using
the SPSS software. All data were expressed as means ± S.D.,
and the differences were considered significant at p < 0.05.
RESULTS
General Characterization of Grx2 Knock-out Mice — Following the generation of Grx2 knock-out mice, we determined
whether replacement of exon 2 with a neomycin resistance
cassette disrupts expression of the mouse Grx2 gene. Surprisingly, as shown in Figure 2A, tissues of homozygous Grx2
knock-out mice still express a slightly smaller species of Grx2
mRNA at a lower abundance than the transcripts present in
tissues of WT mice. Because exon 2 is deleted in the disrupted
Grx2 gene, the expressed Grx2 mRNA in homozygous knockout mice is believed to derive from fusion of exons 1, 3, and 4
sequences. This assumption was confirmed by RT-PCR amplification of Grx2 mRNA isolated from mouse hearts. As shown
in Figure 2B, the expected size of the RT-PCR DNA fragment
from WT Grx2 mRNA is 420 bp. However, the disrupted Grx2
allele in knock-out mice gives rise to a 356-bp RT-PCR fragment. The results of DNA sequencing confirmed that the 356bp DNA fragment contains fusion of exons 1 and 3 sequences
(Figure 2C).
As a consequence, translation of protein from this mRNA
will stop in exon 3 due to the shifted reading frame (Figure
2C). The resultant protein will only contain the mitochondrial
translocation signal, which is encoded by exon 1, followed by
eight amino acids translated from the out-of-frame exon 3 sequence. The aberrant Grx2 mRNA is likely susceptible to nonsense-mediated mRNA decay (50), resulting in a lower level of
the mRNA in tissues of heterozygous and homozygous knockout mice compared with that of WT Grx2 mRNA (Figure 2A).
Protein blot study showed an ~50% decrease of Grx2 protein in
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tissues of heterozygous knock-out mice compared with those of
WT mice, and no Grx2 protein was found in the same tissues of
homozygous knock-out mice (Figure 2D).
Characterization of the Eye Lens of Grx2 KO Mice — We
analyzed the lens tissues from the Grx2 KO mice (Grx2−/−)
and could not detect Grx2 protein or its activity. As shown in
a Western blot of the mitochondrial fraction isolated from the
lenses of Grx2 KO mice (Figure 3A and B), the voltage-dependent anion channel (VDAC) protein (a mitochondrial marker
used as loading control) is clearly present, but Grx2 was absent. In contrast, both proteins could be seen in the WT control
mice. The mitochondrial fraction from the same lens showed
no Grx2 activity in the mouse KO sample, but Grx2 activity of
6.7 ± 0.9 milliunits/mg protein was detected in the WT control
(Figure 3B).
To confirm that this Grx2 KO mouse line is Grx2-specific,
we analyzed the lens tissues for other thiol repair enzymes in
the oxidoreductase family, including the cytosolic Grx2 isozyme Grx1, the cytosolic thioredoxin 1 (Trx1), and mitochondrial thioredoxin 2 (Trx2) by immunoblotting analysis using
specific antibodies. Figure 3C indicates that Grx2 gene deletion
does not affect other oxidoreductase enzymes, because levels
of Grx1, Trx1, and Trx2 were equally reactive in the lenses of
KO and WT mice.
To determine whether Grx2 KO mice have a phenotype associated with gross changes in eye or lens development, we
compared the wet weights of the eye mass and the lens from
ages 1, 7, and 16 months from WT and KO mice. Figure 3, D
and E, indicate that such gene deletion does not lead to significant differences in the growth of either the eye mass or lens in
the three age groups between WT and Grx2 KO mice.
Accelerated Cataract Progression in Grx2 KO Mice — The
potential effect of Grx2 deletion on lens transparency during
aging was measured in Grx2 KO mice by comparison with agematched WT mice. As shown in Figure 4A, the lenses were clear
in both KO and WT animals at 3 months of age, but KO animals
exhibited a more rapid loss of transparency and became over
80% cataractous at 11 months, compared with WT mice which
were only 20% cataractous at this age.
When examining the severity of cataracts using an opacity score from 0 to 5, the two animal populations showed extensive disparity, which corroborated with the degree of cataract prevalence. As shown in Figure 4B, the KO group shows
a lens opacity score of 0.1 at 5 months and steadily increases
to 0.92 at 11 months, after which the score rises abruptly to 3.8
and 5.2 at 13 and 16 months, respectively. Similar to the cataract prevalence, the WT showed a slower formation of lens
opacity with a score of 0.25 at 7 months, 0.4 at 9 months, and
1.38 and 1.63 at 13 and 16 months, respectively. In each age
group, cataract development in the WT mice was far less than
that in the KO animals. The opacity scores in the young animals increased predominantly due to increases in nuclear
opacity, although opacity scores in 13–16-month-old mice increased due to development of additional cortical and postsubcapsular opacity.
The images of slip lamp observation in representative eyes
of both KO and WT animals at 3, 5, 8, and 16 months old are
shown in Figure 4C. In general, the lens opacity in both animal
groups first appeared in the center of the lens, or the nuclear region, and gradually spread out into the cortical, posterior, and
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Figure 2. General
characterization of Grx2
knock-out mice.
A, RNA blot analysis of
Grx2 mRNA expression
in tissues of wild-type and
Grx2 knock-out mice. The
RNA blot membrane was
hybridized with a mouse
Grx2 cDNA and then
re-hybridized with a rat
cDNA for glyceraldehyde3-phosphate
dehydrogenase (G3PD).
B, RT-PCR amplification
of wild-type and mutant
Grx2 mRNA isolated from
mouse hearts.
C, sequence of the junction
between exon 1 and exon
3 of the mutant Grx2
mRNA and the encoded
amino acids.
D, protein blot analysis of
Grx2 in tissues of wildtype and Grx2 knockout mice. The protein
blot membrane initially
reacted with a rabbit antimouse Grx2 antiserum.
A duplicate protein blot
membrane prepared
from a second gel loaded
with the same amount
of samples reacted
with rabbit anti-human
copper-zinc superoxide
dismutase (CuZnSOD)
antibodies for confirming
equal loading of proteins
in each set of tissue
samples from mice with
three different genotypes.
A, B, and D, +/+, +/−,
and −/− represent wildtype, heterozygous
Grx2 knock-out, and
homozygous Grx2 knockout mice, respectively.

posterior subcapsular areas as the animals aged. As shown in
Figure 4C, lower panel, lens opacity of the KO group was clearly
seen in the nuclear region at 5 months and gradually expanded
into an opaque ring at the outer cortical layers by 8 months, and
eventually into full lens involvement in the 16-month-old mice.
In contrast, lens opacity did not appear in the wild-type mouse
(Figure 4C, upper panel) until 8 months, when a light opacity appeared in the nuclear zone, and then a full cortical involvement
was seen in the 16-month-old mouse.
Lens GSH and PSH Levels in Grx2 KO Mice — Because
Grx2 reduces the disulfide linkages of S-glutathionylated proteins and thus may function as an essential repair enzyme to
maintain the SH groups in lens structural proteins in a reduced
state, we examined the levels of reduced glutathione (GSH) and
free thiol in proteins (PSH) of the lenses in the population of
WT and Grx2 KO mice. In general, both GSH and PSH levels
were suppressed in the mouse lens during aging. Figure 5A

shows that the change in GSH was mild in WT mice, where
GSH remained constant up to 7 months and only decreased
by 25% at 16 months. However, the change was more drastic
in the KO animals. Although the GSH level in the 1-month-old
KO mice was the same as that of the age-matched WT mice, it
dropped to 80 and 33% in the 7- and 16-month-old mice, respectively. A similar pattern was observed in the PSH levels of
the lenses shown in Figure 5B, in which the WT level decreased
more slowly than that of the KO group. In the 1-month-old animals, the WT lost 10% of PSH levels of lenses in both the 7- and
16-month age groups, but the KO animals lost 25 and 30% at 7
and 16 months of age, respectively.
Effect of Grx2 Gene Deletion on the Level of Protein-Thiol
Mixed Disulfides in the Mouse Lens — Formation and accumulation of protein-thiol mixed disulfides, either PSSG or
PSSC in the lens, have been implicated to be part of the mechanism of protein misfolding and protein-protein aggregation

G r x 2 G e n e D e l e t i o n I n d u c e s E a r ly O n s e t

of

A g e - d e p e n d e n t C ata r a c t s

in

Mice

36131

Figure 3. Characterization and validation
of the eye lenses of Grx2 KO mice.
The Grx2 KO mouse (5 months old)
lens was evaluated for the presence of
Grx2 expression and disulfide reductase
activity, as well as the effects on other
oxidoreductase enzymes, including
the cytosolic glutaredoxin 1 (Grx1) and
thioredoxin 1(Trx1), and the mitochondrial
thioredoxin 2 (Trx2). The effect of Grx2
gene deletion on eye and lens development
was evaluated by examining the eye and
lens wet weight during aging with samples
from 1-, 7-, and 16-month-old animals.
A, mitochondrial fractions (40 μg) isolated
from 5-month-old WT and Grx2 KO mice
were analyzed for Grx2 expression by
Western blot with anti-Grx2 antibody. A
mitochondrion-specific protein, voltagedependent anion channel (VDAC), was
used as marker and loading control.
B, Grx2 disulfide reductase activity in the lens
of WT and Grx2 KO mice was measured
using the same mitochondrial fraction (100
μg). Data are expressed as means ± S.D.,
n = 3, ***, p < 0.001 versus age-matched
WT.
C, aliquot of lens lysate (40 μg) was used
to detect Grx1 and Trx1, whereas the
mitochondrial fraction was used for Trx2
measurement by immunoblot analysis
using anti-Grx1, anti-Trx1, or anti-Trx2
antibody, respectively. β-Actin was used as
a loading control for Grx1 and Trx1 protein
expression in the WT and KO samples
(upper and middle panels), whereas VDAC
was the loading control for Trx2 analysis of
the WT and KO samples (bottom panel).
Pixel densities of Grx1 and Trx1 were
normalized to the β-actin band, and Trx2
was normalized to VDAC and is depicted in
a bar graph.
D, comparisons of the eye mass (mg)
between WT and Grx2 KO mice in mg of
wet weight.
E, comparisons of lens in mg of wet weight
between WT and Grx2 KO mice. Data are
expressed as means ± S.D., n = 8.

in cataractogenesis (7). Because Grx2 deletion resulted in
faster cataract development during aging (Figure 4), we examined whether the PSSG and PSSC levels were elevated in
the lenses of KO mice relative to the age-matched WT control.
The method measured PSSG and PSSC in the lens by quantification of their in vitro-derived products glutathione sulfonic
acid (GSO3H) and cysteic acid (CSO 3H), respectively (40).
Figure 6A shows the chromatographic separation of CSO3H
and GSO3H in lenses obtained from 1, 7, and 16-month-old
WT and KO mice, with elution of CSO3H and GSO3H standards as the controls. The concentrations of PSSG are shown
in Figure 6B, in which PSSG in 1-month-old mice is low and
similar for WT and Grx2 KO lenses (0.05 ± 0.02 versus 0.06 ±
0.03 μmol/g wet weight). By 7 and 16 months, the PSSG levels in WT mice were 0.09 ± 0.02 μmol/g wet weight and 0.15 ±
0.02, respectively, although PSSG levels in Grx2 KO mice were
much higher at 0.13 ± 0.04 μmol/g wet weight (p < 0.05) and
0.2 ± 0.03 (p < 0.01), respectively.

A similar pattern was observed in the PSSC levels. As
shown in Figure 6C, the PSSC levels in the 1-month-old lenses
of WT and KO mice were 0.19 ± 0.03 and 0.21 ± 0.04 μmol/g
wet weight, respectively. The lens PSSC accumulated with aging but much more so when Grx2 gene is deleted. By 7 months
of age, PSSC in the KO group was 2-fold higher than that of
the WT (0.51 ± 0.04 versus 0.29 ± 0.05 μmol/g wet weight). This
trend continued to 16 months, with PSSC elevated to 0.82 ± 0.12
μmol/g wet weight in the KO lenses and 0.54 ± 0.04 μmol/g
wet weight in the age-matched WT controls.
Accumulation and Identification of PSSG Proteins in Grx2
KO Mouse Lenses — To further examine the effect of Grx2
gene deletion on lens protein S-glutathionylation or PSSG formation, lens homogenates from WT and Grx2 KO mice were
examined by immunoblotting with the anti-PSSG-specific antibody. As shown in Figure 7A, aging progressively induces
accumulation of S-glutathionylated proteins in the lenses of
both WT and KO groups (see arrows). At 1 month of age, PSSG
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Figure 4. Evaluation of the
cataract prevalence rate and
opacity score in the aging
populations of Grx2 KO mice
and age-matched WT mice.
A, prevalence rate of cataract
in Grx2 KO mice (●) and
WT mice (■). Side panel
shows the number of opacity
eyes over the total eyes in
respective Grx2 KO and WT
mice, corresponding to the
ages of the animals.
B, opacity score in WT and
Grx2 KO mice. Opacity was
quantified using the LOCS II
system, and the sum of the
scores was used to analyze
the severity of the cataract.
The same ophthalmologist
gave the cataract scores
without prior knowledge of the
mouse genotype. *, p < 0.05
versus age-matched WT.
C, slit lamp images of
representative eyes. Lenses
of Grx2 KO and age-matched
WT mice ranging from 3 to 16
months (m) were examined.
Eyes were dilated under
nonanesthetized conditions.

in both groups was equally low with one major band between
37 and 50 kDa and another at 25 kDa. In the 7-month-old
lenses, the KO mice showed more PSSG in these regions compared with that of WT controls, with an additional band appearing at ~15 kDa. Further elevation of PSSG was seen in the
lenses of 16-month-old KO mice. The pixel density of the total
GSH antibody-positive protein bands in Figure 7A is depicted
on the right. These results corroborate the PSSG analysis in

Figure 6B, indicating that the Grx2 null animal is more susceptible to age-related PSSG accumulation.
To identify the target proteins of Grx2, S-glutathionylated proteins were immunoprecipitated from the lenses of
16-month-old Grx2 KO mice using anti-PSSG antibody, separated by SDS-PAGE, followed by Coomassie Blue staining. The
immunoreactive GSH-positive proteins (indicated by arrows in
Figure 7B) were excised, digested with trypsin, and subjected
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Figure 5. Quantification of free GSH, PSH, in the lenses of WT
and Grx2 KO mice. Lenses from Grx2 KO and WT mice (1, 7,and 16
months old) were used for this study. Eight individual lens homogenates
were used for the GSH and PSH analysis. A, free GSH levels in Grx2
KO and age-matched WT mice. Data are expressed as means ± S.D.,
n = 8, *, p < 0.05; **, p < 0.01. B, PSH levels in the lenses of WT and
Grx2 KO mice were calculated from the difference between total SH
groups and the GSH levels. Data are expressed as means ± S.D., n =
8, *, p < 0.05; **, p < 0.01 versus age-matched WT.

for identification by LC-MS/MS. This analysis identified several major lens structural proteins that immunoprecipitated
with anti-PSSG antibody, including actin, βB2-crystallin, and
αA-crystallin. However, sites of S-glutathionylation were not
identified, because their relative abundance, compared with
unmodified peptides, was low.
To confirm and quantify the presence of S-glutathionylated
actin, βB2-crystallin, or αA-crystallin identified by LC-MS/
MS analyses, immunoprecipitation and immunoblotting were
carried out. Total PSSG proteins were first precipitated from
whole lens homogenates of WT or Grx2 KO mice using antiPSSG antibody, followed by probing with specific antibodies
against actin, βB2-crystallin, or αA-crystallin. As shown in Figure 7, C–E, and the respective pixel density graphs, in 1-monthold mice the level of glutathionylated actin or βB2-crystallin is
low in both WT and Grx2 KO mice, although no glutathionylated αA-crystallin is found. However, all three proteins were
increasingly glutathionylated in an age-dependent manner in
both WT and Grx2 KO lenses. The PSSG levels in Grx2 null
mice were consistently higher than those of the age-matched
WT controls. As depicted in the pixel density graphs of Figure
7, C–E, a 2.5-, 3.5-, or 3.5-fold elevation of glutathionylated actin, βB2-crystallin, or αA-crystallin was found, respectively, in
the 16-month over the 1-month-old mouse.
ATP Levels in the Lenses of the WT and Grx2 Knock-out
Mice — We have previously demonstrated in the lens epithelial cells (36, 38) that Grx2 protects the mitochondrial respiratory electron transport system and ATP production. Therefore,
we examined the status of in vivo ATP formation in the lenses of
Grx2 KO mice during aging. Figure 8 summarizes the ATP production in the Grx2 KO and age-matched WT mice in three age
groups. At 1 month, ATP levels in WT and Grx2 KO lens were
the same (90.3 ± 10.2 versus 91.0 ± 20.3 μg/mg lens wet weight),
but this basal level decreased with age, with a faster depletion
in the Grx2 null mice than in the WT controls. By 7 months,
the lenses in WT and Grx2 KO mice were 75.2 ± 8.9 and 60.3 ±
10.6 μg/mg lens wet weight, respectively. By 16 months old,
the ATP level was further decreased to 20.3 ± 5.42 μg/mg lens
wet weight (25% of the 1 month level) in the WT animals, and
a barely detectable amount of 1.5 ± 0.5 μg/mg lens wet weight
(<2% of 1-month level) in the lenses of Grx2 KO mice.
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S-Glutathionylated Complex I and Complex IV in the Mitochondrial Respiratory Chain of the Eye Lenses — Complex I, or
NADH dehydrogenase, is the entry point and the first enzyme
system of the mitochondrial respiratory chain for O2 reduction
and ATP generation. We used purified mitochondria from the
lenses of WT or KO mice to determine whether Grx2 gene deletion affects the function of mitochondrial complex I during
aging. Figure 9A shows that complex I activity is similar in the
lenses of 1-month-old WT and Grx2 KO mice (278.4 ± 20.3 versus 261.5 ± 32.5 milliunits/g lens wet weight), and the activity
was gradually lost during aging. However, Grx2 KO mice at 7
and 16 months displayed much lower activity compared with
that of age-matched WT controls. The 7-month-old WT mice
showed complex I activity of 243.2 ± 34.5 milliunits/g lens wet
weight (87% of 1 month old) but Grx2 KO mice had only 172.5
± 28.9 milliunits/g lens wet weight (66% of 1 month old). The
16-month-old WT mice displayed complex I activity at 182.5 ±
19.2 milliunits/g lens wet weight (65% of 1 month old) but only
130.8 ± 12.3 milliunits/g lens wet weight (50% of 1 month old)
in the Grx2 null mice.
We have recently reported (38) that under oxidative stressed
conditions, complex I activity in the lens epithelial cells is suppressed due to S-glutathionylation of its 75-kDa catalytic subunit. Therefore, we explored the possibility that similar modification may occur in the lenses of aging Grx2 KO mice in vivo.
The 75-kDa subunit of complex I was immunoprecipitated from
the mitochondrial fraction obtained from either WT or Grx2 KO
mouse lenses followed by immunoblotting with anti-PSSG antibody to detect the S-glutathionylated 75-kDa protein band. As
shown in Figure 9B, the 75-kDa band was immunoreactive with
the anti-PSSG antibody in the 16-month-old Grx2 KO sample,
and nearly 3-fold higher than that of the age-matched WT control (see the pixel density graph).
Because complex IV is an important downstream regulator
for the mitochondrial respiratory chain, we also explored the
potential effects of Grx2 gene deletion on complex IV. Figure
9C shows that, similar to the results for complex I, complex IV
activity was decreased during aging in both Grx2 KO and WT
groups but more drastically in the KO animals. The complex
IV activity in the 7- and 16-month-old WT animals was suppressed to 82 and 33%, respectively, but the activity at the same
ages in the KO animals was suppressed more, to only 49 and
16%, respectively.
To examine whether S-glutathionylation may affect the activity of the 16-kDa catalytic subunit of complex IV in the absence of the Grx2 gene, we immunoprecipitated this subunit
using the mitochondrial fractions isolated from the lenses of
16-month-old Grx2 KO and WT mice. The results shown in Figure 9D confirm that more S-glutathionylation is found in this
subunit from the Grx2 KO mice than that of the WT control. The
increase of PSSG in the KO animal was nearly 2-fold over the
WT control (see the pixel density graph in Figure 9D).
DISCUSSION
Although Grx2 is believed to play a major role in regulating
thiol/disulfide balance of mitochondria, its function in vivo in a
whole animal remains elusive. We sought to evaluate the physiological role of Grx2 in the pathogenesis of cataract by producing a line of knock-out mice with global Grx2 deficiency. The
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Figure 6. Quantification of
protein-thiol mixed disulfides
in the lenses of WT and Grx2
KO mice. Two duplicate samples
processed from six pooled
lenses of the KO or WT mice
were used for the protein mixed
disulfide quantification. Details are
described under “Experimental
Procedures.”
A, typical chromatograms of PSSC
and PSSG analyses. PSSG
and PSSC standards at 5 nmol
(panel a) and 10 nmol (panel
b); WT samples from 1 month
(panel c), 7 months (panel e),
and 16 months (panel g); KO
samples from 1 month (panel
d), 7 months (panel f), and 16
months (panel h).
B, quantified PSSG level
expressed as μmol/g wet lens
weight.
C, quantified PSSC level
expressed as μmol/g wet lens
weight. Data are expressed
as means ± S.D. based on
triplicate experiments.
*, p < 0.05 vs age-matched WT;
**, p < 0.01 vs age-matched
WT.

Grx2 KO mouse model used in this study has been shown to
lack Grx2 in the lens, in agreement with its absence in other tissues (see Figs. 2D and 3A). Interestingly, deletion of Grx2 did
not affect the expression of other major oxidation repair enzymes in the oxidoreductase family. Therefore, it is likely that
the phenotype displayed in this animal model is mostly, if not
solely, due to Grx2 gene deletion.

Based on these results, it is of interest to note that Grx2 gene
deletion produces a phenotype of early onset and faster progression in cataract formation during aging, in comparison
with the age-matched wild-type mice. In this Grx2 KO mouse
model, the opacity first appeared in the nuclear zone at the center of the lens, and it gradually spread outward into the outer
cortical and posterior subcapsular regions. Such changes were
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Figure 7. Detection of
glutathionylated proteins
(PSSG) in the lenses of WT and
Grx2 KO mice.
A, comparison of protein
glutathionylation in the lens of
WT and Grx2 KO mice. Soluble
fraction of lens homogenates
from WT and Grx2 KO mice
(1, 7, and 16 months old) were
analyzed by Western blotting
using anti-PSSG antibody
under nonreducing conditions.
GAPDH was used as a loading
control. The graph on the
right depicts the relative pixel
density of all the PSSG bands
(indicated by arrows) over
GAPDH (with the 1-montg-old
WT normalized to 1.0).
B, S-glutathionylated protein
identification. Whole lens lysate
from 16-month-old Grx2 KO
mice was immunoprecipitated
for glutathionylated proteins
using anti-PSSG antibody
and then was separated
with SDS-polyacrylamide gel
followed by Coomassie Blue
staining. Proteins showing
positive immunoreactivity
(indicated by arrows) with
anti-PSSG antibody were
cut and identified by liquid
chromatography-tandem mass
spectrometry as predominantly
actin, αA-crystallin, and βB2crystallin. For confirmation,
glutathionylated proteins were
immunoprecipitated (IP) by
using anti-PSSG antibodies,
followed by immunoblot (IB)
detection of actin (C), βB2crystallin (D), and αA-crystallin
(E). Blots labeled “IB: actin,”
“IB: αA-crystallin”, and “IB:
βB2-crystallin” are control
Western blots for actin, βB2crystallin, and αA-crystalline,
respectively. The right panels
show the pixel density graphs
of glutathionylated actin, βB2crystallin, or αA-crystalline in
comparison with the 1-monthold WT lens, respectively. Data
represent the means ± S.D. of
three independent experiments.
*, p < 0.05 versus age-matched
WT;
**, p < 0.01 versus agematched WT.

very visible by the time the mice reached 13–16 months of age
(Figure 3).
Age-related cataract (ARC) or senile cataract is a very common health problem in the current human aging population
and is the leading cause of blindness in the world. Extensive

evidence has linked oxidative stress with the mechanism of
ARC formation (7, 51, 52). Many attempts have been made
to develop an oxidative stress-induced cataract model in animals, but few have shown any close correlation to ARC.
Wolf et al. (53) demonstrated that deletion of glutathione
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Figure 8. ATP level in the lenses of WT and Grx2 KO mice. Whole
lens homogenates from WT and Grx2 KO mice (1, 7, and 16 months
old) were used for ATP measurement with an ATP assay kit. Total ATP
levels in micrograms/lens wet weight are expressed as means ± S.D.,
n = 6, *, p < 0.05; **, p < 0.01.

peroxidase 1 gene (Gpx1), a major H2O2-degrading enzyme,
resulted in a faster cataract progression during aging. However, based on the gross cataract scoring system and a handheld slit lamp, they observed only a 20–30% higher opacity at the advanced age of 26 months in the Gpx1 null mice
Figure 9. Detection of glutathionylated
complex I and complex IV in the
mitochondria of lenses from WT and
Grx2 KO mice. Mitochondrial fractions
isolated from the lenses of WT and Grx2
KO mice (1, 7, and 16 months old) were
used for enzymatic activity assays and
Western blot analyses.
A, complex I activity.
B, comparison of the glutathionylated
complex I protein (75-kDa subunit)
from 16-month-old Grx2 KO and WT
mice. Mitochondrial samples were
immunoprecipitated, followed by Western
blot detection of complex I 75-kDa
subunit. The top panel shows the antiGSH positive immunoprecipitated (IP)
sample followed by identification by anticomplex I 75-kDa subunit antibody. The
relative pixel density of the immunoblots
(IB) of WT and Grx2 KO is shown in the
bar graph after normalizing the WT value
to 1.0. **, p < 0.01 versus WT.
C, complex IV activity. Data are expressed
as means ± S.D., n = 6. *, p < 0.05; **, p
< 0.01 versus WT.
D, comparison of the glutathionylated
complex IV protein (16-kDa subunit)
from 16-month-old Grx2 KO and WT
mice. Mitochondrial samples were
immunoprecipitated, followed by Western
blot detection of complex IV 16-kDa
subunit. Top panel shows the anti-GSH
positive immunoprecipitated sample
followed by identification of anti-complex
IV 16-kDa subunit antibody. The relative
pixel density of the immunoblots of WT
and Grx2 KO is shown in the bar graph
after normalized the WT value to 1.0. **,
p < 0.01 versus WT.
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compared with the age-matched controls. In contrast, we used
a clinical slit lamp and a quantitative LOCS II cataract grading system for this study. Our model showed an early onset
of lens opacity at 5 months, 3 months earlier than that of the
control mice. The cataract prevalence of the Grx2 KO mice was
also consistently higher as a function of age in multiple aging populations. The Grx2 null mice also displayed a progressive and steady increase in lens opacity, faster than that of the
WT mice, with a 20–30% higher score as early as 7–8 months
of age, and a >100% higher score by the age of 13–16 months.
Furthermore, Grx2 is a disulfide reductase, which has a specific catalytic function to reduce the PSSG target proteins accumulated in the lens during aging that is associated with oxidation. Reducing the accumulated PSSG in the early stage of
protein oxidation can prevent the lens proteins from further
modification into PSSP conjugates and the downstream high
molecular weight aggregates that can lead to cataract formation. As far as we know, our current Grx2 null mouse model
provides the first evidence that lacking this oxidative damage
repair enzyme can lead to accelerated cataract formation during aging. Thus, we propose that the Grx2 KO mouse line can
be a good model to study human ARC.
Previously, we (7) have proposed that the initiation of oxidative stress-induced cataract may, in part, involve the oxidation-induced PSSG formation in the lens enzymes/proteins,
resulting in loss of enzyme activity, such as observed with
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Figure 10. Potential
mechanism for Grx2 gene
deletion-induced cataract
formation.
A, proposed mechanism
of ROS release into the
cytosolic region of the
cells.
B, hypothesis for the thiol/
disulfide imbalanceinduced cataract formation
in the lens.
GR, glutathione reductase
Grx, glutaredoxin
Trx(R), reduced thioredoxin
Trx(O), oxidized
thioredoxin
TR, thioredoxin reductase
PSSG, S-glutathionylated
proteins
PSSP, protein-protein
disulfides
ROS, reactive oxygen
species

glyceraldehyde-3-dehydrogenase (20) or protein function, as
with the chaperone-like function of αA-crystallin (54). The extra charge and mass of the –SG group that S-conjugates onto a
protein may cause conformational change (55) and/or destabilization of lens crystallin proteins (56, 57). These types of reactions may allow multiple modified lens proteins to aggregate
and become water-insoluble. Progressive accumulation of such
large particles during aging will eventually lead to cataract formation. The Grx2 KO mice showed similar alterations to those
found in old human clear (13, 58) or opaque lenses (51, 55). In
the Grx2 KO mice soon after lens opacification was initiated,
the GSH pool was suppressed at 7 months and more so at 16
months of age. In the same lens, the PSH level was also correspondingly suppressed in these two age groups, indicating
PSSP accumulation had taken place. Accompanying the loss in
GSH and PSH, these lenses showed considerable elevation of
PSSG and more so of PSSC, which is to be expected, as PSSG is
a far better substrate than PSSC for Grx enzymes (19). In contrast, the wild-type mice with a normal rate of transparency
loss during aging displayed much less change in GSH, PSH,
and protein-thiol mixed disulfides.
Such discrepancies in the rate of age-related cataract progression between WT and KO mice is likely due to the presence of Grx2 in the WT mice. Reducing the accumulated PSSG
in the early stage of protein oxidation can prevent the lens proteins from further modification into PSSP conjugates and the

downstream high molecular weight aggregates that can lead
to cataract formation. However, even the aging WT animals
would succumb to the aging effect due to the chronic oxidative stress from the environment and the decline in antioxidants
and oxidation damage repair enzymes (7, 12). Thus, the effect
on lens transparency begins and progresses, albeit slower than
that of the mice without a Grx2 presence.
Our mass spectrometry and immunoprecipitation studies
have identified several lens structural proteins that have been
in part modified into PSSG and accumulated in the lens. Of the
three proteins shown in Figure 7, αA-crystallin is an important and abundant structural protein. It possesses a chaperonelike function that stabilizes and maintains other lens proteins
in a soluble form. However, on S-glutathionylation of one or
both of its two SH groups, αA-crystallin’s chaperone-like function can be drastically lost (54). Therefore, absence of Grx2 in
the Grx2 KO mice likely contributes to the malfunction of αAcrystallin in the lens with a higher probability for compromised
lens transparency.
Lens lacking Grx2 can affect the mitochondrial functions in
the lens. Previous studies have indicated that Grx2 is a key regulator of redox homeostasis in the mitochondria, and it controls
complex I activity in the electron transport system (ETS) for oxygen reduction and ATP production (37, 38). The results in this
study as shown in Figs. 8 and 9 further support our earlier observation in the primary cell culture obtained from lenses of
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Grx2 KO mice that the 75-kDa catalytic subunit of complex I has
been, in part, S-glutathionylated, resulting in lower complex
I activity (38). In addition, this study showed that the downstream member of the ETS system, complex IV, has also suffered from activity loss, possibly due to S-glutathionylation at
its 16-kDa subunit. The compromised ETS system in the Grx2
KO mice has resulted in lower ATP production. Furthermore,
it is very likely that the oxygen free radical generated from incomplete oxygen reduction inside the mitochondria would leak
out into cytosol, overwhelming the cytosolic capacity of Grx1
to protect the cytosolic proteins/enzymes from oxidative stress,
leading to oxidation and malfunction of these proteins (see Figure 10A). Although Grx2 in other mammalian tissues is known
as an iron-sulfur protein and associated with iron metabolism,
such property has never been explored in the lens and it worth
the attention for future investigation.
Grx1 has recently been found to be present in the intermembrane space of the mitochondria (59). Our soluble mitochondrial preparation used for Grx2 disulfide reductase activity
assay may likely contribute from mitochondrial Grx1 as both
Grxs reduce the synthetic substrate (β-hydroxyethyl disulfide)
used in this study, but we did not detect any Grx2 activity in
the lens preparation of the Grx2 KO mice (Figure 3B). However, as the mitochondrial Grx1 is located in the intermembrane
space of the mitochondria, it should not interfere with or contribute to the function of Grx2 located in the mitochondrial matrix, where the ETS system is protected by this isozyme.
Besides the current evidence that mitochondrial Grx deletion
may directly affect lens transparency, mice with global cytosolic
Grx1 KO also displayed a phenotype of faster cataract progression with age (M. F. Lou, unpublished results), and its isolated
lens epithelial cells became extra-sensitive to oxidation and were
prone to apoptosis (60), parallel to its mitochondrial isoform.
Thus, the Grx family is essential in protecting lens transparency.
In conclusion, Grx2 gene deletion induces a phenotype of
faster progression of cataracts during aging, likely contributed
from the combination of chaperone-like function loss and compromised mitochondrial functions. This is a first animal model
that displays a close association to the absence of a single oxidative damage repair gene in the mitochondria with cataract
progression that mimics the age-related cataract in humans.
Results in the current studies provide further evidence for our
previous hypothesis shown in Figure 10B that oxidative stressinduced thiol/disulfide imbalance at the stage of PSSG accumulation is the first critical checkpoint to prevent the cascading
events leading to cataract formation (7). The findings also suggest that Grx protein may be a potential anti-cataract agent for
delaying or slowing down the age-related cataracts in humans.
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